Related Experiment Video
Updated: Dec 21, 2025

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
Combination of ceftaroline and daptomycin as treatment for complicated osteomyelitis
Ana Gascón1, Marta Castresana2, Natalia Alzueta3
1Pharmacy, Hospital Reina Sofia Navarre Health Service, Tudela, Spain am.gascon.villacampa@navarra.es.
Abstract:
Osteomyelitis is an infection involving bone. Staphylococcus aureus is the pathogen most frequently implicated; less frequently involved are other gram-positive organisms, such as Staphylococcus epidermidis, and also gram-negative organisms. The antibiotic of choice for treatment of osteomyelitis caused by methicillin-resistant staphylococci (MRS) is vancomycin, although other alternatives such as daptomycin or teicoplanin are also considered. Osteomyelitis caused by MRS can be difficult to treat safely and effectively. This case report describes the successful use of daptomycin combined with ceftaroline for the treatment of osteomyelitis caused by methicillin-resistant S. epidermidis (MRSE) in a 54-year-old woman, emphasising the clinical pharmacist's role in antimicrobial stewardship programmes. This alternative combination has been studied in the treatment of methicillin-resistant S. aureus (MRSA), but it may also be useful in MRSE.
Insights
This case report details a successful treatment for bone infection (osteomyelitis) caused by methicillin-resistant Staphylococcus epidermidis (MRSE). A combination of daptomycin and ceftaroline proved effective, offering a new therapeutic option.
Area of Science:
- Infectious Diseases
- Pharmacology
- Microbiology
Background:
- Osteomyelitis is a bone infection often caused by Staphylococcus bacteria.
- Methicillin-resistant staphylococci (MRS) present treatment challenges.
- Vancomycin is a common treatment, but alternatives are explored.
Observation:
- A 54-year-old woman had osteomyelitis caused by methicillin-resistant Staphylococcus epidermidis (MRSE).
- Previous treatments for MRS osteomyelitis can be difficult to manage.
- The patient was treated with a combination of daptomycin and ceftaroline.
Findings:
- The combination of daptomycin and ceftaroline was successfully used to treat MRSE osteomyelitis.
- This antibiotic regimen offers an alternative to standard treatments.
- The clinical pharmacist played a key role in antimicrobial stewardship.
Implications:
- This combination therapy may be a viable option for MRSE infections.
- Further research into daptomycin and ceftaroline for resistant staphylococcal infections is warranted.
- Highlights the importance of clinical pharmacists in managing complex infections.
More Related Videos
11:15Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
12:03Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Endocarditis III: Medical Management
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Endocarditis IV: Nursing Management